Stay updated with breaking news from Nasdaq Atra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pinnacle Associates Ltd. lessened its holdings in Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) by 0.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 449,704 shares of the biotechnology company’s stock after selling 2,123 shares during the period. Pinnacle Associates Ltd.’s holdings in Atara Biotherapeutics were worth […]
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) have been given a consensus rating of “Buy” by the seven ratings firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to […]
StockNews.com started coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Get Rating) in a note issued to investors on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. Several other equities analysts have also issued reports on ATRA. Canaccord Genuity Group lowered their target price on shares of Atara Biotherapeutics from $78.00 […]
Atara Biotherapeutics (NASDAQ:ATRA – Get Rating) had its price target cut by research analysts at JPMorgan Chase & Co. from $27.00 to $22.00 in a report issued on Monday, The Fly reports. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 134.04% from the stock’s current price. Several other research analysts also […]